Virtual Cardiac Rehabilitation Produces Similar Results as In-Person Treatment

Translate to Spanish or other 102 languages!

Cardiac rehabilitation (CR) reduces hospitalization and mortality and improves quality of life for patients with cardiovascular disease. Despite its benefits, only 24 percent of eligible patients in the U.S. participate in CR due to financial and logistical barriers. Image for illustration purposes
Cardiac rehabilitation (CR) reduces hospitalization and mortality and improves quality of life for patients with cardiovascular disease. Despite its benefits, only 24 percent of eligible patients in the U.S. participate in CR due to financial and logistical barriers. Image for illustration purposes

Mega Doctor News

- Advertisement -

By University of California, San Francisco (UCSF)

Newswise — Cardiac rehabilitation (CR) reduces hospitalization and mortality and improves quality of life for patients with cardiovascular disease. Despite its benefits, only 24 percent of eligible patients in the U.S. participate in CR due to financial and logistical barriers.

When the COVID-19 pandemic limited in-person treatment options for CR, cardiovascular rehabilitation centers, including UC San Francisco, added virtual and hybrid options. In a study published in the most recent issue of The Journal of Cardiopulmonary Rehabilitation and Prevention, UCSF researchers looked at the efficacy of hybrid and virtual delivery of CR. They found that virtual and hybrid CR services produced similar improvements in patient function as in-person CR.

- Advertisement -

“Our primary objectives were to compare the association of in-person, hybrid and virtual CR with functional changes in patients between enrollment in the program through completion,” said Alexis Beatty, MD, MAS, a UCSF cardiologist and associate professor of Epidemiology & Biostatistics. “Not only did we find similar outcomes for virtual and hybrid CR as in-person CR, but we also found that virtual and hybrid CR have the potential to expand availability without compromising outcomes.”

Patients enrolled in CR between October 2019 and May 2021, and were categorized into in-person, hybrid, or virtual groups by number of in-person and virtual visits. All patients received individualized exercise training and health behavior counseling. Cardiac rehabilitation was delivered to patients in the hybrid and virtual groups using synchronous video exercise and/or asynchronous telephone visits. Measurements at CR enrollment and completion included a 6-minute walk test, blood pressure, depression, anxiety, waist-to-hip ratio, and cardiac self-efficacy.

Hybrid and virtual patients experienced similar improvements in blood pressure control, a 6-minute walk test and anxiety. While virtual patients experienced less improvement in depression symptoms, they generally had positive perceptions of hybrid and virtual CR.

Cardiac rehabilitation holds tremendous promise but is underutilized and often unavailable according to heart experts. These results provide evidence that hybrid and virtual CR programs are practical options for increasing CR capacity and flexibility to meet patients’ needs.

- Advertisement -

Authors: Smitha Ganeshan, MD, MBA; Hunter Jackson, BA; Donald J. Grandis, MD; David Janke, MA, BS; Michelle L. Murray, MSN, BS, RN; Vanessa Valle, CEP; Alexis L. Beatty, MD, MAS

Funding: Funding sources can be found in the paper.

About UCSF: The University of California, San Francisco (UCSF) is exclusively focused on the health sciences and is dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. UCSF Health, which serves as UCSF’s primary academic medical center, includes top-ranked specialty hospitals and other clinical programs, and has affiliations throughout the Bay Area. UCSF School of Medicine also has a regional campus in Fresno. Learn more at ucsf.edu or see our Fact Sheet.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Expanded Use of Kidney Cancer Treatment Rooted in UTSW Discovery

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug. This move marks the latest expansion of belzutifan’s indications after it was originally approved in 2021.

STHS to Raise Awareness of PTSD in Latest South Texas Healthy Living Episode, June 28th

If you’re experiencing intrusive, distressing memories or feeling constantly on edge following a traumatic event, you may be living with post-traumatic stress disorder (PTSD) and you’re not alone. 

STHS Highlights Life-Saving Habits for Men

While men face unique health challenges, experts say routine preventive care, healthy lifestyle habits and early intervention can significantly improve health outcomes and overall quality of life.

Health Experts Issue Comprehensive Roadmap to Reduce Kids’ Sugar Intake

American children consume more than double the recommended amount of added sugars each day, contributing to rising rates of childhood obesity, type 2 diabetes, and other chronic health conditions.
- Advertisement -